Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 2000, p. 602-607, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Antibacterial and Antimembrane Activities of
Cecropin A in Escherichia coli
Loraine
Silvestro,1
Jeffrey N.
Weiser,2 and
Paul H.
Axelsen1,3,*
Department of
Pharmacology1 and Infectious Disease
Section, Department of Medicine, The Johnson Foundation for Molecular
Biophysics,3 University of Pennsylvania School
of Medicine, and the Departments of Pediatrics and
Microbiology, Children's Hospital of
Philadelphia,2 Philadelphia, Pennsylvania
19104-6084
Received 16 July 1999/Returned for modification 31 October
1999/Accepted 3 December 1999
 |
ABSTRACT |
The ability of cecropin A to permeabilize and depolarize the
membranes of Escherichia coli ML-35p bacteria has been
compared to its bactericidal activity in an extension of earlier
studies performed on synthetic lipid vesicle membranes (L. Silvestro, K. Gupta, J. H. Weiser, and P. H. Axelsen, Biochemistry
36:11452-11460, 1997). Our results indicate that differences in the
concentration dependences of membrane permeabilization and
depolarization seen in synthetic vesicles are not manifested in whole
bacteria. The concentration dependences of both phenomena roughly
correlate with bactericidal activity, suggesting that the bactericidal
mechanism of cecropin A is related to membrane permeabilization.
 |
INTRODUCTION |
Cecropin A is one of the most
extensively studied antimicrobial polypeptides among the many that are
produced by insects as components of their host defense systems against
bacterial infection (6, 7, 14). While there is a broad
consensus that the site of antibacterial action of these polypeptides
is the plasma membrane, the precise mechanism
and the way in which
they discriminate between bacterial and host cell membranes
remains unclear.
Studies of cecropin A and related peptides have shown that cecropin A
is a linear 37-residue polypeptide composed entirely of ordinary
L-amino acids (21). It is unstructured in
aqueous solution but has the potential to form
-helices in partially organic solvent (8, 19). Early studies of their bactericidal mechanism suggested that cecropins bind to negatively charged membrane
lipids and form a closely packed layer (20) or "carpet" of peptide (5, 15) which renders the membranes permeable. Later studies demonstrated that cecropins form partially selective ion
channels (2). Evidence against a mechanism involving
specific chiral receptors was provided by studies showing that
analogues composed entirely of D-amino acids retained full
activity (22). Models have been proposed for the ion channel
formed by cecropins (3), and evidence is available
indicating that they aggregate and assume a transbilayer orientation in
membranes (12, 13). We have recently shown that the action
of cecropin A on synthetic lipid vesicles is concentration dependent,
forming ion channels at low peptide/lipid ratios and "pores" large
enough to pass various probe molecules at higher peptide/lipid ratios
(16). In that set of experiments we demonstrated that
leakage of water-soluble probe molecules was "all or nothing,"
supporting the idea that the pores through which the probes escape are
stable, water-filled transmembrane conduits.
One limitation of many studies of antimicrobial peptide action is that
they have been performed on synthetic lipid vesicles rather than
bacteria. This is necessary in many cases to make particular types of
studies feasible or interpretable. However, vesicle studies leave
important questions open about the true nature of antimicrobial peptide
action in a vastly more complex chemical milieu. Therefore, we have
extended our earlier studies of cecropin A action on phospholipid
vesicles to whole bacteria.
 |
MATERIALS AND METHODS |
Materials.
Cecropin A, with the sequence +KWKLFKKIEK
VGQNIRDGII KAGPAVAVVG QATQIAK-CONH, was synthesized by standard
solid-phase methods at the Mayo Peptide Core Facility (Rochester,
Minn.). After purification by reversed-phase high-performance liquid
chromatography (LC), it was confirmed to have a molecular weight of
4005 by mass spectrometry (MS). DiSC3(5)
(3,3'-dipropylthiodicarbocyanine) was obtained from Molecular Probes
(Eugene, Oreg.) and prepared as a stock solution of 2 mM in ethanol.
EDTA and valinomycin were obtained from Fluka (Uppsala, Sweden).
Melittin, ONPG
(o-nitrophenyl-
-D-galactopyranoside), and
Tris were obtained from Sigma (St. Louis, Mo.). Melittin was prepared
as a 1-mg/ml stock solution in 10 mM Tris buffer. ONPG was prepared as
a 25 mM stock in the same buffer and shielded from light during
storage. Peptide concentrations were determined by a bicinchoninic acid
assay (Pierce, Rockford, Ill.) with an albumin standard.
Escherichia coli strain ML-35 (lacI lacY
lacZ+) transformed with plasmid pBR322 (to yield
ML-35p) (11) was a gift from Robert I. Lehrer (University of
California
Los Angeles).
Bactericidal activity.
Bacteria were grown to mid-log phase
at 37°C in Luria-Bertani medium, centrifuged (1,000 × g; 10 min), resuspended in buffer (150 mM Tris, pH 7), washed
twice in 10 mM Tris, pH 7, and brought to 108 CFU/ml
(assuming an optical density at 620 µm [OD620] of 0.35 corresponded to 108 CFU/ml). They were then diluted 10 times in 135 µl of 10 mM Tris buffer containing cecropin A (0 to 5 µM). After 10-min incubations at 25°C, the suspensions were placed
on ice and diluted 10- to 10,000-fold in 10 mM Tris buffer, and 10-µl
aliquots were spotted on Luria-Bertani agar plates for overnight
culture at 30°C and manual counting of CFU with the assistance of a
dissecting microscope.
Inner membrane integrity.
E. coli ML-35p
constitutively expresses cytoplasmic
-galactosidase and periplasmic
-lactamase and is ampicillin resistant and lactose permease
deficient (10, 11). The expression of
-lactamase is not
relevant to these experiments, but the presence of
-galactosidase in
the cytoplasm enables one to assess inner membrane integrity by
immersing the cells in a solution of a chromogenic substrate. The
organisms were grown to stationary phase at 37°C, centrifuged, and
washed as described above and then diluted to an OD620 of
0.35 in 10 mM Tris buffer, pH 7. A 15-µl aliquot of the washed
suspension was further diluted in 135 µl of 10 mM Tris buffer
containing 2.5 mM ONPG and between 0 and 20 µM cecropin A in 96-well
microtiter plates for a final volume of 150 µl per well. The
hydrolysis of ONPG to o-nitrophenol (ONP) in each well was
followed by measuring the absorbance at 415 nm at 1-min intervals for
60 min at 25°C with a Bio-Rad 550 plate reader. For positive and
negative controls, melittin (23 µM) or DiSC3(5) (12 µM)
was substituted for cecropin A.
Membrane depolarization.
Membrane depolarization
measurements were performed with DiSC3(5), a lipophilic
potentiometric dye that changes its fluorescence intensity in response
to changes in transmembrane potential. Bacteria in mid-log phase were
centrifuged (1,000 × g; 10 min), washed in 150 mM
Tris, incubated with 1 mM EDTA in 150 mM Tris buffer (pH 7) for 15 min
at 25°C, washed twice with 10 mM Tris (pH 7), and finally diluted to
an OD620 of 0.35 in 10 mM Tris buffer (pH 7). A 100-µl
aliquot of the bacterial suspension was added to 900 µl of the
dilution buffer, followed by 1 µl of DiSC3(5) stock (17). The steady-state fluorescence intensity at 668 ± 1.7 nm was measured in a 4- by 10-mm stirred cell with a Fluorolog 2 spectrofluorimeter SPEX (Edison, N.J.) in a right-angle configuration and with excitation at 606 ± 1.7 nm. After allowing the dye
signal to stabilize for about 4.5 min, 5 µl of a solution of cecropin A in 10 mM Tris at pH 7 was added. The concentration of the peptide solution added was adjusted to yield final concentrations between 0 and
5.0 µM. In experiments similar to those previously conducted with
liposomes, we demonstrated that light scattering due to bacteria was
negligible under these conditions (data not shown) (16). The
level of ethanol from the DiSC3(5) stock solution did not exceed 0.1% in any experiment. Fluorescence intensities after various
additions were volume corrected, and the results are expressed as a
percentage change in signal intensity.
LC-MS.
To measure the concentration of cecropin A remaining
free in solution during the membrane depolarization experiments (i.e., peptide that had not adsorbed to bacteria), a bacterial suspension with
2.5 µM cecropin A prepared as for a membrane depolarization experiment was centrifuged to produce a bacterium-free supernatant. A
10-µl aliquot of the supernatant along with a set of cecropin A
standards was spiked with an internal standard (substance P) and
separated via high-performance LC on a 1.0-mm by 25-cm Phenomenex (Torrance, Calif.) Primesphere C18 column operated at a
flow rate of 400 µl/min, with a mobile phase of 0.05%
trifluoroacetic acid in water and an acetonitrile gradient increasing
from 18 to 45% over 30 min. The separation was monitored by a mass
spectrometer (Quattro II; Micromass Inc., Beverly, Mass.) equipped with
a coaxial electrospray probe and triple-quadrupole analyzer. The
sampling-cone voltage was set to 40 V, the capillary voltage was set to
3.5 kV, and the source temperature was set to 65°C. The mass analyzer was set in single-ion recording mode for the analyte and
internal-standard ions.
 |
RESULTS |
Bactericidal activity.
Cecropin A killed E. coli
ML-35p quickly and at low concentrations. We observed 50 and 90%
killing after 10-min incubations in 0.9 and 1.7 µM cecropin A,
respectively (Fig. 1), and >99% killing
after 10 min at 2.5 µM. These concentrations are comparable to the
antimicrobial activity we reported previously for cecropin A against
K-1 and K-12 strains of E. coli (16). Control
experiments showed that 23 µM melittin was >99.9% lethal but that
12 µM DiSC3(5) was not toxic.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Viability of E. coli ML-35p bacteria after a
10-min incubation with cecropin A. The error bars represent ± 1 standard deviation for an n of 3.
|
|
Inner membrane integrity.
Permeabilization of the inner
membrane of E. coli strain ML-35p was followed by adding a
suspension of bacteria to a buffer containing ONPG and cecropin A and
measuring the absorbance of ONP at 415 nm versus time. ONP is produced
by the action of cytoplasmic
-galactosidase on ONPG. ONPG does not
penetrate the inner membranes of intact bacteria and remains
extracellular because E. coli strain ML-35p is deficient in
lactose permease. Agents that compromise inner membrane integrity
permit ONPG to diffuse into the bacterial cell, where it is hydrolyzed
to ONP.
The addition of bacterial suspensions to a solution of cecropin A and
ONPG caused [ONP] (i.e., the concentration of ONP) to rise and
plateau (Fig. 2A). This plateau
represents substrate depletion, because the same amount of ONPG
substrate was present in each experiment. The addition of bacteria to
23 µM melittin caused this plateau to be reached faster than the
highest concentration of cecropin A used (20 µM), while control
substances [including DiSC3(5)] did not accelerate ONP
production beyond baseline levels. Centrifugation of a bacterial
suspension treated for 20 min with 2.5 or 5.0 µM cecropin A, or 23 µM melittin, resulted in a supernatant devoid of measurable
-galactosidase activity, indicating that these treatments did not
release
-galactosidase from bacterial cells into the medium. Neither
valinomycin nor DiSC3(5) (used as described below for
membrane depolarization studies) permeabilized the membrane enough to
result in measurable ONP production.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 2.
ONP production kinetics. Each datum point represents an
average of three independent trials. Experimental conditions were
chosen so that complete hydrolysis of ONPG yielded an absorbance of
1.0. Valinomycin and DiSC3(5) resulted in ONP levels
indistinguishable from those of the buffer control; melittin produced
ONP faster than 20 µM cecropin A. (A) Results for 60 min. (B) Results
for the first 10 min.
|
|
We analyzed these data assuming that there are three basic processes
influencing d[ONP]/dt, the rate of ONP
production at any given concentration of cecropin A. First, simple
hydrolysis of ONPG produces ONP at a constant rate, i.e.,
d2[ONP]/dt2 = 0.
Second, permeabilization increases ONP production only insofar as it is
a rate-limiting process. As the membrane is permeabilized, the
opportunity for
-galactosidase to act on ONPG increases, and
d2[ONP]/dt2 > 0.
Third, substrate depletion decreases the rate of ONP production and
yields a d2[ONP]/dt2
value of <0.
To simplify our analysis, we analyzed only the first 10 min (after a
1-min mixing period) to eliminate the influence of substrate depletion
on the rate of ONP production (Fig. 2B). The concentration of ONP over
this interval, which is proportional to its absorbance [A(t)], is well described by a second-order polynomial:
[ONP]t = k · A(t)415 = at2 + bt + c, where k is a scaling constant. The rate of ONP production is therefore given by the equation
d[ONP]/dt = 2at + b, and changes in rate are given by the equation
d2[ONP]/dt2 = 2a. Plots of the second- and first-order coefficients (a and b) recovered versus cecropin A
concentration are shown in Fig. 3.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
First- (A) and second (B)-order coefficients for
polynomials describing the rate of ONP production shown in Fig. 2B. The
vertical axes are scaled so that points at identical positions in both
graphs would make equal quantitative contributions to the amount of ONP
produced at 10 min.
|
|
The second-order coefficient a (Fig. 3B) and the constant
c (not shown) are virtually 0 over the range of cecropin A
concentrations examined. This indicates that membrane permeabilization is fast on the time scale of these measurements and is not a
rate-limiting process over this time period. The rate of ONP production
appears to be a first-order process described by the coefficient
b, and this coefficient is linearly related to the log of
the peptide concentration. This relationship between b and
peptide concentration suggests that a process other than
peptide-induced permeability limits the rate of ONPG hydrolysis, e.g.,
substrate diffusion. If b was an exponential function of
[cecropin A], this would suggest that several cecropin A molecules
were required to form a structure that permeabilized the membrane. This
may be the case at lower concentrations and over shorter times. On the
time and concentration scales of these experiments, however, the linear
dependence of b on the logarithm of [cecropin A] indicates
that progressively smaller fractions of cecropin A are involved in
permeabilizing the membrane as [cecropin A] increases.
Membrane depolarization.
Cecropin A-induced changes in the
bacterial membrane potential were measured with the potentiometric dye
DiSC3(5). Upon addition to a suspension of bacterial cells,
DiSC3(5) partitions into the cell membranes and
equilibrates within 20 s (Fig. 4).
Cecropin A was added approximately 4 min after the fluorescence
emission intensity stabilized. This caused an immediate increase in
fluorescence intensity, indicating rapid membrane depolarization (Fig.
4). The dye response in whole bacteria was further characterized by adjusting external potassium ion concentrations in the presence of
valinomycin. This demonstrated that some depolarization occurred with 5 mM external potassium (implying that the internal potassium concentration is somewhat lower) and that 25 mM potassium could be
expected to cause a greater-than-100% increase in fluorescence intensity (Fig. 5). In response to
cecropin A, depolarization was minimal at concentrations of
1.25
µM, but 5 µM peptide caused a >60% increase (Fig.
6).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 4.
Fluorescence intensity of DiSC3(5) in
E. coli. Increases and decreases in fluorescence intensity
represent membrane depolarization and hyperpolarization, respectively.
After the addition of DiSC3(5) to the bacterial suspension,
equilibration is nearly complete within 30 s. Data collection was
stopped for 10 s while dye and cecropin A were added so that
injection artifacts would not be seen.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 5.
Fluorescence intensity changes of DiSC3(5)
in E. coli in the presence of valinomycin and various
external potassium ion concentrations, showing that depolarization by
elevated external potassium can result in a fluorescence intensity
increase of over 100%.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 6.
Fluorescence intensity changes of DiSC3(5)
in E. coli upon exposure to cecropin A. The error bars
represent standard deviations.
|
|
Experimental constraints required that cecropin A be added as a small
volume of concentrated stock solution to a much larger volume of
bacterial suspension. This transiently exposed some bacteria in the
suspension to concentrations much higher than the nominal
concentration, and those bacteria may have absorbed enough peptide to
make the actual concentration of free peptide lower than the nominal
concentration. Therefore, bacterial suspensions prepared as for a
membrane depolarization experiment with a nominal peptide concentration
of 2.5 µM were centrifuged for 10 min at 1,000 × g.
The supernatant was assayed for cecropin A by LC-MS with substance P as
an internal standard and a set of cecropin A solutions in buffer as
calibration and retention time standards. This experiment found 1.4 µM cecropin A remaining in the supernatant
a concentration
sufficient to kill at least 80% of the bacteria present.
 |
DISCUSSION |
Two technical considerations bear critically on the interpretation
of these results. First, we measured the bactericidal activity of
cecropin A by using a survival assay in liquid medium. This was the
most appropriate measurement because our purpose was to compare
antimicrobial activity to the concentrations required to permeabilize
the inner bacterial membrane. Because permeabilization is most likely a
lethal rather than inhibitory event, MICs derived from growth
inhibition assays were not suitable for our purpose. Furthermore,
published methods for determining MICs for cecropin A appear to depend
on assumptions about peptide diffusion in agar or agarose
(9), and the results vary with the technique and materials
used (1).
Second, inner membrane integrity was measured by adding aliquots of a
bacterial suspension to a known concentration of peptide. This approach
avoided the exposure of some bacteria to high concentrations of peptide
that occurs when aliquots of a concentrated peptide solution are added
to a bacterial suspension. The same approach was used when measuring
bactericidal activity, but for technical reasons this approach was not
possible when measuring changes in membrane potential.
These technical considerations are relevant to a comparison of the
bactericidal and the permeabilizing activities of cecropin A (Fig. 1
and 3). The threshold concentrations for the onset of both activities
are similar and on the order of 0.25 µM. By itself, this suggests
that the bactericidal activity of cecropin A is related to its
permeabilizing activity. However, bactericidal activity was maximal at
2.5 µM peptide, while this concentration yielded only a half-maximal
rate of ONP production. Thus, permeabilizing activity lagged behind
bactericidal activity as the peptide concentration was increased.
The simplest explanation for this lag is that any permeabilization of
the membrane is lethal but that the hydrolytic capacity of cellular
-galactosidase exceeded the amount of ONPG that entered the cells
through the membrane permeabilized by 2.5 µM peptide. The enzyme was
unlikely to be saturated with substrate, since its extracellular
concentration (0.7 µM) was the same as the Km of
-galactosidase at low magnesium concentrations (18).
Thus, higher concentrations of peptide can increase the rate of ONPG hydrolysis by increasing the extent to which the membrane is
permeabilized. They would not, however, be any more effective at
killing bacteria. It remains entirely possible that bactericidal
activity and permeabilizing activity are not directly related (as
demonstrated recently for another cationic antimicrobial peptide
[4]), but a close relationship between these
activities is suggested by their similar thresholds of activity. This
contrasts sharply with our earlier studies of lipid vesicles, which
indicated that much higher concentrations of cecropin A were needed to
cause permeability changes (16).
We could not measure the depolarizing activity of cecropin A by the
same technique used to measure bactericidal or permeabilizing activity
because the intensity of DiSC3(5) depends on its
partitioning across a membrane. As a consequence, injecting
DiSC3(5)-labeled bacteria into a known concentration of
peptide (as we did to measure bactericidal and permeabilizing
activities) dilutes extracellular DiSC3(5) and causes
changes in its signal intensity that are not related in a simple way to
dilution or changes in membrane potential. For this reason, we elected
to add small volumes of concentrated cecropin A to a bacterial
suspension equilibrated with DiSC3(5).
Therefore, the results of these membrane depolarization studies must be
interpreted cautiously. They are most remarkable for what did not
happen: a nominal peptide concentration of 1.4 µM is >80% effective
in a bactericidal assay (Fig. 1), but a free concentration of 1.4 µM
did not even come close to fully depolarizing bacterial membranes.
While a rigorous quantitative comparison cannot be made because of
differences in technique, Fig. 3, 5, and 6 suggest that the amount of
depolarization is roughly comparable to the limited level of ONP
production expected at the same concentration. This again contrasts
sharply with our earlier lipid vesicle experiments, in which
permeability changes required much higher concentrations of peptide
than did membrane potential changes (16).
Our ability to establish the bactericidal mechanism of cecropin A by
comparing the time dependences of various phenomena is limited because
the time dependences of the three assays we have employed in this study
(survival, permeability, and potential change) are all fundamentally
different. The effect of cecropin A on inner membrane integrity over a
10-min period may not reflect peptide-induced lethal effects that
persist after the bacteria have been exposed to peptide for a 10-min
period. On the other hand, the concentration dependence of
depolarization and permeabilization in whole bacteria is roughly
similar to the concentration dependence of bactericidal activity,
suggesting that both bactericidal activity and membrane depolarization
may be consequences of membrane permeabilization. These results are in
sharp contrast to the concentration dependence we had previously
observed in lipid vesicles (16), and they underscore the
difficulties of drawing conclusions about bactericidal mechanisms from
studies of synthetic membranes.
In other antimicrobial peptides it has been possible to manipulate
antimicrobial activity by means of experimental conditions and to show
that it is independent of membrane-permeabilizing activity, leading
some investigators to the critical suggestion that the site of action
may not be the cytoplasmic membrane (23, 24). This may
eventually prove to be the case with cecropin A as well, although our
data neither support nor refute this possibility. This conclusion
awaits a demonstration that the antimicrobial and
membrane-permeabilizing activities of cecropin A can be manipulated separately by means of experimental conditions. In the meantime, the
thrust of the results presented here indicates that these activities
exhibit similar concentration dependences in whole bacteria and that
differences in the concentration dependences of membrane
permeabilization and depolarization observed in synthetic vesicles are
not manifested in whole bacteria.
 |
ACKNOWLEDGMENTS |
P.H.A. is supported by NIH grant GM54617 and a grant-in-aid from
the American Heart Association.
We are grateful to Elena Lysenko, Misha Shchepetov, Miki Kapoor, Jane
Gould, Jean Kim, and Nina Pan for assistance with bacterial cell
culture; to Robert I. Lehrer and Yoon Cho for E. coli ML-35p bacteria; and to participants in the Second Gordon Research Conference on Antimicrobial Peptides for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pharmacology, University of Pennsylvania, 3620 Hamilton Walk,
Philadelphia, PA 19104-6084. Phone: (215) 898-9238. Fax: (215)
573-2236. E-mail: axe{at}pharm.med.upenn.edu.
 |
REFERENCES |
| 1.
|
Boman, H. G.,
D. Wade,
I. A. Boman,
B. Wahlin, and R. B. Merrifield.
1989.
Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.
FEBS Lett.
259:103-106[CrossRef][Medline].
|
| 2.
|
Christensen, B.,
J. Fink,
R. B. Merrifield, and D. Mauzerall.
1988.
Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes.
Proc. Natl. Acad. Sci. USA
85:5072-5076[Abstract/Free Full Text].
|
| 3.
|
Durell, S. R.,
G. Raghunathan, and H. R. Guy.
1992.
Modeling the ion channel structure of cecropin.
Biophys. J.
63:1623-1631[Abstract/Free Full Text].
|
| 4.
|
Friedrich, C.,
M. G. Scott,
N. Karunaratne,
H. Yan, and R. E. W. Hancock.
1999.
Salt-resistant alpha-helical cationic antimicrobial peptides.
Antimicrob. Agents Chemother.
43:1542-1548[Abstract/Free Full Text].
|
| 5.
|
Gazit, E.,
A. Boman,
H. G. Boman, and Y. Shai.
1995.
Interaction of mammalian antibacterial cecropin P1 with phospholipid vesicles.
Biochemistry
34:11479-11488[CrossRef][Medline].
|
| 6.
|
Hancock, R. E. W., and D. S. Chapple.
1999.
Peptide antibiotics.
Antimicrob. Agents Chemother.
43:1317-1323[Free Full Text].
|
| 7.
|
Hoffmann, J. A.
1995.
Innate immunity of insects.
Curr. Opin. Immunol.
7:4-10[CrossRef][Medline].
|
| 8.
|
Holak, T. A.,
A. Engstrom,
P. J. Kraulis,
G. Lindeberg,
H. Bennich,
T. A. Jones,
A. M. Gronenborn, and G. M. Clore.
1988.
The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study.
Biochemistry
27:7620-7629[CrossRef][Medline].
|
| 9.
|
Hultmark, D.,
Å. Engström,
K. Andersson,
H. Steiner,
H. Bennich, and H. G. Boman.
1983.
Insect immunity. Attacins, a family of antibacterial proteins from Hyalophora cecropia.
EMBO J.
2:571-576[Medline].
|
| 10.
|
Lehrer, R. I.,
A. Barton,
K. A. Daher,
S. S. L. Harwig,
T. Ganz, and M. E. Selsted.
1989.
Interaction of human defensins with Escherichia coli.
J. Clin. Investig.
84:553-561.
|
| 11.
|
Lehrer, R. I.,
A. Barton, and T. Ganz.
1988.
Concurrent assessment of inner and outer membrane permeabilization and bacteriolysis in E. coli by multiple- wavelength spectrophotometry.
J. Immunol. Methods
108:153-158[CrossRef][Medline].
|
| 12.
|
Mchaourab, H. S.,
J. S. Hyde, and J. B. Feix.
1993.
Aggregation state of spin-labeled cecropin AD in solution.
Biochemistry
32:11895-11902[CrossRef][Medline].
|
| 13.
|
Mchaourab, H. S.,
J. S. Hyde, and J. B. Feix.
1994.
Binding and state of aggregation of spin-labeled cecropin AD in phospholipid bilayers: effects of surface charge and fatty acyl chain length.
Biochemistry
33:6691-6699[CrossRef][Medline].
|
| 14.
|
Oren, Z., and Y. Shai.
1998.
Mode of action of linear amphipathic alpha-helical antimicrobial peptides.
Biopolymers
47:451-463[CrossRef][Medline].
|
| 15.
|
Pouny, Y.,
D. Rapaport,
A. Mor,
P. Nicolas, and Y. Shai.
1992.
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes.
Biochemistry
31:12416-12423[CrossRef][Medline].
|
| 16.
|
Silvestro, L.,
K. Gupta,
J. N. Weiser, and P. H. Axelsen.
1997.
The concentration-dependent membrane activity of cecropin A.
Biochemistry
36:11452-11460[CrossRef][Medline].
|
| 17.
|
Sims, P. J.,
A. S. Waggoner,
C. H. Wang, and J. F. Hoffman.
1974.
Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles.
Biochemistry
13:3315-3330[CrossRef][Medline].
|
| 18.
|
Sinnott, M. L., and S. G. Withers.
1978.
The necessity of magnesium cation for acid assistance aglycone departure in catalysis by Escherichia coli (lacZ) beta-galactosidase.
Biochem. J.
175:539-546[Medline].
|
| 19.
|
Steiner, H.
1982.
Secondary structure of the cecropins: antibacterial peptides from the moth Hyalophora cecropia.
FEBS Lett.
137:283-287.
|
| 20.
|
Steiner, H.,
D. Andreu, and R. B. Merrifield.
1988.
Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects.
Biochim. Biophys. Acta
939:260-266[Medline].
|
| 21.
|
Steiner, H.,
D. Hultmark,
Å. Engström,
H. Bennich, and H. G. Boman.
1981.
Sequence and specificity of two antibacterial proteins involved in insect immunity.
Nature
292:246-248[CrossRef][Medline].
|
| 22.
|
Wade, D.,
A. Boman,
B. Wåhlin,
C. M. Drain,
D. Andreu,
H. G. Boman, and R. B. Merrifield.
1990.
All-D amino acid-containing channel-forming antibiotic peptides.
Proc. Natl. Acad. Sci. USA
87:4761-4765[Abstract/Free Full Text].
|
| 23.
|
Wu, M. H., and R. E. W. Hancock.
1999.
Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane.
J. Biol. Chem.
274:29-35[Abstract/Free Full Text].
|
| 24.
|
Wu, M. H.,
E. Maier,
R. Benz, and R. E. W. Hancock.
1999.
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
Biochemistry
38:7235-7242[CrossRef][Medline].
|
Antimicrobial Agents and Chemotherapy, March 2000, p. 602-607, Vol. 44, No. 3
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bucki, R., Sostarecz, A. G., Byfield, F. J., Savage, P. B., Janmey, P. A.
(2007). Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother
60: 535-545
[Abstract]
[Full Text]
-
Bucki, R., Byfield, F. J., Janmey, P. A.
(2007). Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J
29: 624-632
[Abstract]
[Full Text]
-
Pham, H. T., Riu, K. Z., Jang, K. M., Cho, S. K., Cho, M.
(2004). Bactericidal Activity of Glycinecin A, a Bacteriocin Derived from Xanthomonas campestris pv. glycines, on Phytopathogenic Xanthomonas campestris pv. vesicatoria Cells. Appl. Environ. Microbiol.
70: 4486-4490
[Abstract]
[Full Text]
-
Bucki, R., Pastore, J. J., Randhawa, P., Vegners, R., Weiner, D. J., Janmey, P. A.
(2004). Antibacterial Activities of Rhodamine B-Conjugated Gelsolin-Derived Peptides Compared to Those of the Antimicrobial Peptides Cathelicidin LL37, Magainin II, and Melittin. Antimicrob. Agents Chemother.
48: 1526-1533
[Abstract]
[Full Text]
-
Bhargava, K., Feix, J. B.
(2004). Membrane Binding, Structure, and Localization of Cecropin-Mellitin Hybrid Peptides: A Site-Directed Spin-Labeling Study. Biophys. J
86: 329-336
[Abstract]
[Full Text]
-
Hong, R. W., Shchepetov, M., Weiser, J. N., Axelsen, P. H.
(2003). Transcriptional Profile of the Escherichia coli Response to the Antimicrobial Insect Peptide Cecropin A. Antimicrob. Agents Chemother.
47: 1-6
[Abstract]
[Full Text]